Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory ...

Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...

Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per ...

US healthcare giant Johnson & Johnson has filed a supplemental Biologics License Application with the US Food and Drug ...

California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human ...

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and ...

Zai Lab and Pfizer have partnered for the commercialization of Xacduro (sulbactam-durlobactam) in China, targeting carbapenem ...

Akeso is awaiting approval from China's medicines regulator for a penpulimab-anlotinib combination therapy for advanced liver ...

Sino Biopharm has invested $20 million to acquire a 4.91% stake in LaNova Medicines, securing rights to LM-108 and other ...